---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
sourceUrl: https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered
type: article
quality: 14
heat: 14
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: https://mms.businesswire.com/media/20200106006021/en/765262/23/NEC.jpg
    width: 1200
    height: 627
    title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"

secured: "hR7JDUz69jwUjF8cXG8zbpx6WzELuSr0jO6tXxJMTMl4RJWnsu15/2aRTEgkudLTL00eu0UlfX9H8bsaRreqaemoLLva6O7H98E9fCtoiyPpRov0MFGdT5DTBvK/OCobe3rYKAdM7Nfcq2WeDUZ2y2TNKDgl5uZeLgEEeiKXMWalC4MtXAM7ZFz6TXX5kM0jev8x+pCWNtKwM5NjrGKmT2gLrlrGqGLKn2YTCsoh4Zz+S+ihYtdFGJZUPiJmAKVawKN2Zor1XHZ6QBpRnUvlY9KLLF/foTMTmCF72PKGlR4b/mANdAf9Kgo1ZsYI0/xp;P655S1q51UyvsPBbDwL46g=="
---

